
Abrar Ahmed
About Abrar Ahmed
Data last updated:
Abrar Ahmed has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Fasma Healthcare Private Limited and Ingenium Bioresearch Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Fasma Healthcare Private Limited at ₹6.78 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Mar 2017 | 2017 | ₹6.78 Cr (FY 2024) | Active | |
| Director | 09 Aug 2017 | 2017 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abrar Ahmed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abrar Ahmed
Abrar Ahmed has 9 years in corporate governance. Holds Director role. Currently with 2 companies, including Fasma Healthcare Private Limited and Ingenium Bioresearch Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Fasma Healthcare Private Limited at ₹6.78 Cr (FY 2024).
Abrar Ahmed is associated with 2 companies as Director, including Fasma Healthcare Private Limited (₹6.78 Cr), Ingenium Bioresearch Private Limited.
Abrar Ahmed has expertise in Healthcare, General Business.
Abrar Ahmed has 9 years in corporate governance.
By reported revenue, the largest current company of Abrar Ahmed is Fasma Healthcare Private Limited, with revenue of ₹6.78 Cr (FY 2024).
Abrar Ahmed currently holds positions at 2 companies: Fasma Healthcare Private Limited (₹6.78 Cr), Ingenium Bioresearch Private Limited.